5 Results for "

veno-occlusive disease

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "veno-occlusive disease" in MCE Product Catalog:

Defibrotide sodium
0 Images
Defibrotide (sodium)
Cat. No.: HY-108746
CAS No.: 83712-60-1
Defibrotide sodium is a complex mixture of single stranded polydeoxyribonucleotides. Defibrotide sodium has liver protection, anti-inflammatory, antithrombotic, profibrinolytic, and anti-ischemic properties. Defibrotide sodium can be used for sinusoidal obstruction syndrome (SOS)/veno-occlusive disease (VOD) research .
loading...
    loading...
Cat. No.: HY-W319647
CAS No.: 315705-10-3
GCN2 activator-1 (Compound 20) is a GCN2 activator. GCN2 activator-1 binds within the ATP-pocket of GCN2 and activates GCN2 in a GCN1-independent manner. GCN2 activator-1 activates Integrated Stress Response (ISR) in cells. GCN2 activator-1 inhibits PKR with an IC50 of 3.75 µM. GCN2 activator-1 can be used for research of pulmonary veno-occlusive disease (PVOD) .
loading...
    loading...
Cat. No.: HY-121390
CAS No.: 303-34-4
Lasiocarpine, a hepatotoxic pyrrolizidine alkaloid (PA), causes fatal liver veno-occlusive disease in vivo. Lasiocarpine is toxic only after its metabolic conversion to the toxic intermediate, including dehydrolasiocarpine and N-oxide .
loading...
    loading...
Cat. No.: HY-121390A
CAS No.: 1976-49-4
Target:  

Endogenous Metabolite

Research Areas:  

Cancer

Lasiocarpine hydrochloride, a hepatotoxic pyrrolizidine alkaloid (PA), causes fatal liver veno-occlusive disease in vivo. Lasiocarpine hydrochloride is toxic only after its metabolic conversion to the toxic intermediate, including dehydrolasiocarpine and N-oxide .
loading...
    loading...
Cat. No.: HY-133589
CAS No.: 6029-87-4
Target:  

Drug Derivative

Fulvine is a pyrrolizidine alkaloid isolated from the seeds of Crotalaria fulva. Fulvine is hepatotoxic and can be used to induce hypertensive pulmonary vascular disease in vivo .
loading...
    loading...